ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BAT8010 tested in patients with advanced cancers
Disease control CompletedThis early-phase study tested a new drug called BAT8010 in 23 people with advanced or metastatic solid tumors that had not responded to standard treatments. The main goals were to find a safe dose and check for side effects. Participants received one of eight different doses ever…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated May 30, 2026 11:20 UTC
-
New drug targets tough tumors in early trial
Disease control CompletedThis study tested an experimental drug called MRG004A in 39 adults with advanced or metastatic solid tumors that have a specific protein called tissue factor. The main goals were to find the safest dose and see if the drug can shrink tumors. This is an early-phase trial, so it fo…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated May 30, 2026 11:17 UTC
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a new drug, TAK-981, combined with the immunotherapy pembrolizumab in 161 adults with advanced or metastatic solid tumors that could not be cured. The main goals were to see if the combination was safe and to measure how well it shrank tumors. Participants recei…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New drug WTX-330 tested in patients with advanced cancers
Disease control CompletedThis early-phase study tested a new drug called WTX-330 in 25 adults with advanced solid tumors or lymphoma that had stopped responding to standard treatments. The main goals were to check safety, find the right dose, and see if the drug shrinks tumors. The study is now complete,…
Matched conditions: ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Werewolf Therapeutics, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC